ADPGK: A Key Enzyme in Cellular Signaling and Disease (G83440)

Target Name: ADPGK

NCBI ID: G83440

ADPGK

ADPGK: A Key Enzyme in Cellular Signaling and Disease

ADPGK (Adenosine Diphosphate-Glycerol Kinase), also known as RbBP-35, is a protein that plays a crucial role in cellular signaling. It is a key enzyme in the adenylyl cyclase/cAMP signaling pathway, which is involved in a wide range of Physiological processes in the body, including regulation of cardiovascular function, neurotransmission, and inflammation.

ADPGK is a 21-kDa protein that is expressed in various tissues and cells in the body. It is primarily localized to the cytoplasm of the cell and can also be found in the nucleus. The protein has a unique structure that is composed of a catalytic active site, a regulatory region, and a C-terminal hypervariable region (HVR).

The catalytic active site of ADPGK is a region that is known for its catalytic activity. It contains a nucleotide-binding oligomerization (NBO) domain, which is responsible for the binding of nucleotides to the enzyme. The NBO domain is composed of a nucleotide- binding loop and a nucleotide-binding extension. The nucleotide-binding loop is the region that binds to the first nucleotide, while the nucleotide-binding extension is the region that binds to the second nucleotide.

The regulatory region of ADPGK is located between the catalytic active site and the C-terminal HVR. It consists of a zinc ion-binding site, a calcium ion-binding site, and a G-protein-coupled receptor (GPCR) binding site. The zinc ion-binding site is located in the NBO domain and is responsible for the binding of zinc ions to the protein. The calcium ion-binding site is located in the regulatory region and is responsible for the regulation of the activity of the enzyme. The GPCR binding site is located in the C-terminal HVR and is responsible for the interaction between the protein and GPCRs.

ADPGK is involved in a wide range of cellular signaling pathways. One of the most well-studied functions of ADPGK is its role in the regulation of aqueous humor formation. Aqueous humor is a clear fluid that is produced by the uveal system and plays a crucial role in maintaining the health and function of the eye. The production and regulation of aqueous humor is involved in a complex cascade of signaling pathways, including the TGF-β pathway, Wnt signaling pathway, and the adenylyl cyclase/cAMP signaling pathway.

ADPGK is a key enzyme in the adenylyl cyclase/cAMP signaling pathway, which is involved in the regulation of aqueous humor formation. The regulation of aqueous humor formation by ADPGK is mediated by the production and activation of cAMP, which is a key signaling molecule in the pathway. The production of cAMP from ADPGK is regulated by various factors, including the concentration of calcium ions and the levels of various signaling molecules, such as TGF-β and Wnt.

In addition to its role in the regulation of aqueous humor formation, ADPGK is also involved in the regulation of a wide range of other physiological processes in the body. For example, it is involved in the regulation of cell growth, differentiation, and apoptosis, as well as in the regulation of inflammation and immune responses.

ADPGK is also a potential drug target. The inhibition of ADPGK has been shown to have a wide range of therapeutic effects, including the treatment of a variety of diseases and conditions, including heart failure, cancer, and neurodegenerative diseases. The use of ADPGK as a drug target is an exciting area of 鈥嬧?媟esearch, as it has the potential to provide new treatments for a wide range of diseases.

In conclusion, ADPGK is a protein that plays a crucial role in cellular signaling. It is a key enzyme in the adenylyl cyclase/cAMP signaling pathway and is involved in the regulation of a wide range of physiological processes in the body. The inhibition of ADPGK has been shown to have a wide range of therapeutic effects, including the treatment of a variety of diseases and conditions. Further research is needed to fully understand the role of ADPGK as a drug target and to develop new treatments for a wide range of diseases.

Protein Name: ADP Dependent Glucokinase

Functions: Catalyzes the phosphorylation of D-glucose to D-glucose 6-phosphate using ADP as the phosphate donor. GDP and CDP can replace ADP, but with reduced efficiency (By similarity)

The "ADPGK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADPGK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets